Browse as ListSearch Within- Section 639.263 - False or misleading advertising
- Section 639.264 - Prohibition against unearned rebate, refund or other consideration for referrals
- Section 639.265 - Pharmacists may trade or exchange drugs if necessary for business
- Section 639.2655 - Use of computerized mechanical equipment to perform act required to be performed by pharmacist
- Section 639.266 - Communication of information to patient or person caring for patient
- Section 639.2665 - Required posting or provision of written instructions relating to safe disposal of unused drugs by retail community pharmacy; penalties
- Section 639.267 - Return, reissuance or transfer of unused drugs: Drugs packaged in unit doses generally; regulations
- Section 639.2675 - Return, reissuance or transfer of unused drugs: Drugs dispensed by pharmacy to offender in correctional institution; written procedures for returning; regulations
- Section 639.2676 - Unused drugs transferred to nonprofit pharmacy: Authority to reissue; immunity from civil and criminal liability and disciplinary action; written procedures for accepting and reissuing; regulations
- Section 639.268 - Purchase of controlled substances, poisons, dangerous drugs and devices by practitioner; acquisition of controlled substances and dangerous drugs directly from outsourcing facility; sale of controlled substances or dangerous drugs to persons or agencies which provide emergency care; records; regulations
- Section 639.270 - Sales of unrestricted drugs, medicines, remedies, poisons or chemicals by grocers and dealers
- Section 639.275 - Computer or other electronic device provided to practitioner by pharmacy or insurer
- Section 639.2801 - Requirements for labeling containers for prescribed drugs
- Section 639.28013 - Duty to provide certain information for prescribed drugs in English and certain other languages upon request; exception; posting of rights and list of languages; regulations; civil liability related to contracts for translation
- Section 639.28015 - Retail community pharmacy required to provide notice of availability of prescription reader; provision of prescription reader; exceptions
- Section 639.2802 - Availability of information concerning prices of prescriptions
- Section 639.28025 - Notice of availability of list of prices for drugs and professional services to be posted
- Section 639.2803 - Dispensing specific drugs when choice of drugs available
- Section 639.2804 - Filling prescriptions for amygdalin and procaine hydrochloride
- Section 639.2805 - Substances licensed for manufacture in Nevada: Filling prescriptions; labeling of containers
- Section 639.2806 - Parenteral solutions: Limitation on sale and dispensing
- Section 639.2807 - Parenteral solutions: Compounding, packaging and labeling; regulations
- Section 639.28075 - Requirements for filling prescription for drug used for contraception; refills; exceptions
- Section 639.28077 - Self-administered hormonal contraceptive: Establishment of protocol for dispensing; regulations
- Section 639.28078 - Self-administered hormonal contraceptive: Conditions and requirements for dispensing; notification to Board; posting by Board of names of notifying pharmacies on Internet website
- Section 639.28079 - Medication-assisted treatment of opioid use disorder: Conditions under which pharmacist registered with Board is authorized to assess and counsel patient and prescribe and dispense drug; regulations regarding registration and establishment of protocol
- Section 639.2808 - Performance of blood glucose test by registered pharmacist or registered intern pharmacist
- Section 639.28085 - Certain drugs for preventing acquisition of human immunodeficiency virus: Ordering and performing necessary laboratory tests for therapy; prescribing, dispensing and administering; coverage by liability insurance; protocol; regulations
- Section 639.28095 - Pharmacist employed by off-site pharmaceutical service provider to provide remote chart order processing services to hospital or correctional institution required to be registered with Board; duty of off-site pharmaceutical service provider to ensure compliance